PANCREATIC CANCER NON-RESECTABLE
Clinical trials for PANCREATIC CANCER NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER NON-RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for inoperable pancreatic cancer: testing a Triple-Threat treatment
Disease control ENROLLING_BY_INVITATIONThis study is testing a three-part treatment for pancreatic cancer that cannot be removed by surgery. It combines a targeted drug (nimotuzumab) with radiation and standard chemotherapy. The main goal is to see if this combination can control the cancer's growth in the treated are…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Can enzyme pills help cancer patients keep weight on?
Symptom relief OngoingThis study is testing whether pancreatic enzyme replacement therapy (PERT) can help people with advanced pancreatic cancer maintain their body weight while on chemotherapy. Researchers are comparing two different dosing schedules of the enzyme supplement pancrelipase. The main go…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt for hidden signs to guide pancreatic cancer treatment
Knowledge-focused OngoingThis study aims to understand why some patients with advanced pancreatic cancer respond to immunotherapy while others do not. Researchers will collect blood, tissue, and stool samples from 100 patients receiving a standard immunotherapy and chemotherapy combination. By analyzing …
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists seek clues to predict which pancreatic cancer treatments will work
Knowledge-focused OngoingThis study aims to create a tool that can predict how well a pancreatic cancer patient will respond to a combination of chemotherapy, immunotherapy, and targeted drugs. Researchers will analyze tissue samples from 70 patients to find biological markers linked to treatment success…
Matched conditions: PANCREATIC CANCER NON-RESECTABLE
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC